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Introduction
The development of antibiotic resistance among pathogenic
bacteria has become a serious problem worldwide. The
overuse of antibiotics in a number of situations is
contributing to the increase in antibiotic resistance in
microorganisms; therefore, the need for the detection and
development of new and effective natural antibiotics is
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In our search for new sources of bioactive secondary metabolites from Streptomyces sp., the
ethyl acetate extracts from endophytic Streptomyces SUK 25 afforded five active
diketopiperazine (DKP) compounds. The aim of this study was to characterize the bioactive
compounds isolated from endophytic Streptomyces SUK 25 and evaluate their bioactivity
against multiple drug resistance (MDR) bacteria such as Enterococcus raffinosus, Staphylococcus
aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter
spp., and their cytotoxic activities against the human hepatoma (HepaRG) cell line. The
production of secondary metabolites by this strain was optimized through Thornton’s
medium. Isolation, purification, and identification of the bioactive compounds were carried
out using high-performance liquid chromatography, high-resolution mass liquid
chromatography-mass spectrometry, Fourier transform infrared spectroscopy, and nuclear
magnetic resonance, and cryopreserved HepaRG cells were selected to test the cytotoxicity.
The results showed that endophytic Streptomyces SUK 25 produces four active DKP
compounds and an acetamide derivative, which were elucidated as cyclo-(L-Val-L-Pro), cyclo-
(L-Leu-L-Pro), cyclo-(L-Phe-L-Pro), cyclo-(L-Val-L-Phe), and N-(7-hydroxy-6-methyl-octyl)-
acetamide. These active compounds exhibited activity against methicillin-resistant S. aureus
ATCC 43300 and Enterococcus raffinosus, with low toxicity against human hepatoma HepaRG
cells. Endophytic Streptomyces SUK 25 has the ability to produce DKP derivatives biologically
active against some MDR bacteria with relatively low toxicity against HepaRG cells line. 
Keywords: Cytotoxicity, diketopiperazines, Enterococcus raffinosus, HepaRG, MRSA, Streptomyces
SUK 25
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important. Streptomyces represent a large group of micro-
organisms that are ubiquitous in nature. Strain Universiti
Kebangsaan 25 (SUK 25) is one strain that belongs to the
genus Streptomyces sp., which was isolated from the root of
Zingiber spectabile [1, 2]. SUK 25 exhibited potential inhibitory
activity against some bacteria, especially against the
methicillin-resistant Staphylococcus aureus (MRSA) strain
during primary and secondary screenings. From SUK 25,
several diketopiperazines (DKPs) were isolated, which were
described from various natural resources [3]. DKPs create a
large class of secondary metabolites synthesized mostly by
human, plants, and microorganisms. DKPs are a class of
cyclic dipeptides and characterized by a heterocyclic
piperazine-2,5-dione synthesized from two amino acid
units. Recently, the interest in these compounds has
significantly increased because of their diverse and
remarkable activity, and 90% of Gram-negative bacteria
can produce DKPs [4]. Furthermore, DKPs have been
isolated from Gram-positive bacteria [5], fungi [6], and
higher marine organisms [7] as well. 
The current study aimed to isolate and elucidate bioactive
secondary metabolites from the endophyte Streptomyces
SUK 25. The antimicrobial activity and cytotoxicity of some
of the isolated compounds were evaluated. Cytotoxicity
assay was carried out using the human hepatoma cell line
named HepaRG, which is a unique cell line that
differentiates canaliculae-like and hepatocyte-like cells
retaining a drug metabolism capacity comparable to that of
primary human hepatocytes and hepatoma carcinoma
(HepG2) cells without inter-donor variability and functional
instability with time in culture, which has been observed in
primary cells [8-10]. In addition, these cells were obtained
from a liver tumor cell of a female patient suffering from
hepatocarcinoma and hepatitis C infection [11].
Materials and Methods
The fermentation, production, and extraction of secondary
metabolites as well as chromatographic fractionation and purification
of isolated compounds were carried out using reverse-phase open
column chromatography and thin-layer chromatography (TLC) as
described earlier [3]. 
Biological Activity
The antibacterial activity of the obtained compounds was tested
against the multidrug resistance (MDR) pathogens Enterococcus
raffinosus, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumanii, Pseudomonas aeruginosa, and Enterobacter sp., collectively
referred to by the acronym ESKAPE. All strains were obtained
from the culture collection of the Novel Antibiotic Laboratory,
Faculty of Health Sciences, Universiti Kebangsaan Malaysia.
Antimicrobial assays were carried out using the disc diffusion
agar method. Antibacterial bioassays were conducted according
to Dobretsov and Qian [12]. Compounds were dissolved in 10%
MeOH at a concentration of 1 mg/ml. Aliquots of 20 µl were
soaked on filter paper discs (6 mm, No. 2668; Schleicher & Schüll,
Germany). A standard antibiotic disc of gentamicin (20 µg/disc)
was used as the positive control and 10% MeOH as the negative
control for comparison. The paper discs were air dried at room
temperature under sterilized conditions. Antibacterial effects
were determined after 24 h of incubation at 37°C by measuring the
diameter of the zone of inhibition. 
MTT Cell Viability Assay for Cytotoxicity Testing
Cell viability was measured by the MTT colorimetric method
[13]. This assay is based on the reduction of the soluble yellow
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
tetrazolium salt to a blue MTT formazan product by mitochondrial
dehydrogenases. This assay was performed to determine the
cytotoxicity of the two compounds namely, cyclo-(L-Val-L-Pro)
and cyclo-(L-Phe-L-Pro). In this study, we followed the protocol
from the manufacturer of cryopreserved HepaRG cells and media
supplements (Millipore, USA). HepaRG cells were seeded in 96-
well plates at a density of 104 cells per well and incubated in 5%
CO
2
 at 37oC for 24 h. The cells were then treated with varying
concentrations from 5 to 120 µg/ml and incubated in 5% CO
2
 at
37oC for 24 h. To determine the cell viability, 20 µl of 5 mg MTT/
ml in PBS was added to each well and incubated in 5% CO
2
 for 4 h
at 37oC. The yellow MTT dye was reduced by succinic
dehydrogenase in the mitochondria of viable cells to purple
formazan crystals. Finally, the medium was carefully replaced
with 200 µl of DMSO and mixed thoroughly to dissolve the
formazan crystal product. Absorbance measurements were
conducted utilizing the microplate spectrophotometer Nano-
Quant infinite M200PRO at A
570
. A positive control composed of
10% DMSO was used as a known cytotoxic natural agent that
gives 100% lethality under the same conditions. The samples also
included a blank (medium alone). All experiments were carried
out with hepatocytes from three independent cell preparations for
each compounds’ concentration.
Cell viability was calculated using the following formula:
Cell viability (%) =  × 100, where OD is the
optical density. The half inhibitory concentration (IC
50
) was defined
as 50% reduction of absorbance compared with the control assay.
Statistical Analysis 
The results were expressed as the mean ± SD for all experiments.
Triplicate experiments of three independent HepaRG isolations
were run, and three wells were used for each set of conditions.
IC
50
 values were calculated using GraphPad Prism 5.
Spectroscopy and Structure Determination of Compounds
Separation and final purification of the crude extract of each
Mean OD of treated cells
Mean OD of control cells
-----------------------------------------------------------------
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fraction were performed using high-performance liquid
chromatography (HPLC) on an Agilent 1200 HPLC system
equipped with a C-18 column (size 4.6 × 250 mm, 5 µm). In
addition, the structure determination of compounds was determined
using nuclear magnetic resonance (NMR) spectroscopy and FT–
NMR spectroscopy at 600 MHz with Cryoprobe AVANCE III
(Bruker, USA). For dereplication and exact mass measurements,
HR-LCMS was measured on an Accela 600 HPLC pump with
Accela autosampler coupled to a UV/Vis detector and an Orbitrap
Exactive mass spectrometer (Thermo Fisher Scientific, Inc., USA).
Analysis of samples was done using similar protocols described
earlier by MacIntyre et al. [14]. Initially, the raw HR-LC/ESI/MS
data were sliced into two data sets according to their ionization
mode using the Mass Convert tool from ProteoWizard (http://
proteowizard.sourceforge.net/). The sliced data were imported to
MZMine 2.10 (http://sourceforge.net/projects/mzmine/), a software
developed for the differential analysis of mass spectrometry data.
The data processing step was performed in the same manner as
explained previously by MacIntyre et al. [14] and Abdelmohsen et
al. [15], albeit with slightly modified parameters. In this analysis,
the data set was crop filtered from 0.1 to 35 min, and the retention
time normalizer was not applied because only one batch of data
was used. The processed data from MZMine was incorporated
into the customized library through the built-in Excel MACRO for
peak identification and dereplication. An algorithm was employed
to use the molecular formula data set from Antibase 2013. The
monoisotopic exact masses for each metabolite were then calculated
to be used for the customized library. “Hits” and identified peaks
were checked against the MS raw data in Xcalibur 2.2.
The FT-IR spectra were recorded on an FT-IR spectrophotometer
(Perkin Elmer, USA) using the potassium bromide (KBr) disc
method. Optical rotation was measured on an Autopol VI automatic
polarimeter (Rudolph Research Analysis, USA). The melting point
was measured on a Stuart apparatus (Bibby Scientific, UK).
Results 
The ethyl acetate extracts from endophytic Streptomyces
SUK 25 produced four DKP compounds and an acetamide
derivative (Fig. 1). They were identified as cyclo-(L-Val-L-
Pro (1), cyclo-(L-Phe-L-Pro) (2), cyclo-(L-Leu-L-Pro) (3), cyclo-
(L-Val-L-Phe) (4), and N-(7-hydroxy-6-methyl-octyl)-acetamide
(5), respectively, and were all isolated from fraction
number II (FII; Table 1) after a series of chromatographic
separation and purification using preparative HPLC.
Structure elucidation was done by 1D and 2D NMR, as well
as HR-LC/ESI/MS, as shown in Tables 2-5. The isolated
DKPs 1, 2, 3, and 4 were obtained as colorless solids from
FII with melting points of 216-221°C. DKPs showed a UV
absorbing band at 280 nm and turned violet upon spraying
with anisaldehyde/sulfuric acid on a TLC silica plate. The
NMR spectral data were comparable to those found in the
literature [16, 17]. The NMR data (Tables 3 and 4) of the
isolated DKP compounds gave characteristics 13C NMR
shifts at approx. 165 and 170 ppm for the amide unit in the
ring system. The 1H NMR resonance at the 4 ppm region is
typical for a methine residue of an α-proton of an amino
acid unit, and the DKPs are synonymous to a cyclic
dipeptide. The obtained NMR data for the proline-bearing
Fig. 1. Cyclo-(L-Val-L-Pro (1), cyclo-(L-Phe-L-Pro) (2), cyclo-(L-Leu-L-Pro) (3), cyclo-(L-Val-L-Phe) (4), and N-(7-hydroxy-6-methyl-
octyl)-acetamide (5).
Table 1. Pure weight, diameter of inhibition zone, and MIC
and MBC values of active fractions of fraction II against MRSA
ATCC 43300.
Fraction No.
Weight 
(mg)
I.Z 
(mm)
MIC 
(µg/ml)
MBC 
(µg/ml)
FII 51 15 8 64
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DKPs were comparable to the L-DKPs described in the
literature [17]. All optical rotation values for proline-
containing DKPs (Table 2) gave a negative sign, indicating
that the proline unit had the S configuration [18]. The IR
spectrum (KBr film) V
max
of the DKPs exhibited absorption
at 3,348, 2,479, 2,070, 1,394, 1,092, 1,121, and 972 cm-1, which
indicated the presence of a C-N stretch and H-C-H-
asymmetric stretch.
Compound 5, N-(7-hydroxy-6-methyl-octyl)-acetamide,
was obtained as a colorless oil from FII as well, showing an
UV absorbing band at 280 nm. It gave a green coloration
with anisaldehyde/sulfuric acid when sprayed on TLC
silica plate. Data of the IR spectrum (KBr film) yielded V
max
absorbance at 3,356, 3,256, 2,966, 2,931, 1,683, 1,650, 1,530,
and 1,447 cm−1. The optical rotation exhibited an [α]D25 value
of −119.9 (c 0.25 in CHCl
3
). 1H and 13C NMR spectroscopies
were used for the characterization of compound 5, which
was elucidated as an aliphatic branched-amide. The NMR
data (Table 5) suggested that this subfraction is similar to
that of N-(7-hydroxy-6-methyl-octyl)-acetamide isolated
from terrestrial Streptomyces sp. GT 2005/079 [19]. The m/z
value of this compound was 202.1802 [M + H] + eluting at
1.25 min. The molecular formula C
11
H
23
NO
2
 was supported
by the integration and multiplicity obtained from the 1H
and 13C NMR data, respectively. N-(7-Hydroxy-6-methyl-
octyl)-acetamide was earlier described to exhibit moderate
Table 2. Name, formula, m/z, R
T
, and O.R° of five active diketopiperazine compounds isolated from fraction II. 
Compound name Formula m/z R
T
O.R°-[α]D
(c = 0.1, MeOH)
Cyclo-(L-Val-L-Pro) (1) C
10
H
16
N
2
O
2
197.1285 3.45 –324.6
Cyclo-(L-Phe-L-Pro) (2) C
14
H
16
N
2
O
2
245.1284 5.33 –138.2
Cyclo-(L-Leu-L-Pro) (3) C
11
H
18
N
2
O
2
211.1441 6.09 –310.4
Cyclo-(L-Val-L-Phe) (4) C
14
H
18
N
2
O
2
247.1440 7.64 –95.84
N-(7-Hydroxy-6-methyl-octyl)-acetamide (5) C
11
H
23
NO
2
202.1802 1.25 −119.9a
a(c 0.25 in CHCl
3
).
Table 3. 1H NMR and 13C NMR spectral data of compounds 1–3 in MeOH-d
4
. 
Position
1 2 3
δ 13C 
(ppm)
δ 13C 
(ppm)a
δ 1H (ppm),
multiplicity (J in Hz)
δ 13C 
(ppm)
δ 
13C 
(ppm)a
δ 1H (ppm),
multiplicity (J in Hz)
δ 13C 
(ppm)
δ 13C 
(ppm)a
δ 1H (ppm),
multiplicity (J in Hz)
1 172.6 (s) 169.7 169.2 169.4 170.3 170.2 
3A 46.6 (t) 45.7 3.49 (m) 44.6 45.4 3.13-3.58 45.5 45.8 3.64-3.54
3B 3.54 (m) 3.13-3.58 3.64-3.54
4 23.6 (t) 22.3 1.92 (m) 21.6 22.5 1.24-1.84 22.7 23.6 2.22-1.98
5A 29.9 (t) 28.5 2.31 (ddd, 11.9, 6.9, 1.3) 27.9 28.3 2.31-2.37 28.1 28.4 4.04
5B 2.00 (m) 2.31-2.37 4.04
6 61.2 (d) 60.3 4.19 (dd, 6.9, 1.3) 58.7 59.0 4.46 (dd 10.6, 2.7) 59.0 59.2 4.15
7 167.6 (s) 164.6 165.7 164.7 166.1 166.2 
9 59.7 (d) 58.7 4.02 (d, 2.5) 56.3 56.1 4.10 (t, 7.6) 53.4 53.6 2.37
10 29.6 (d) 28.3 2.47 (q, 6.9, 6.9, 2.5) 36.3 36.7 3.19 38.6 38.9 2.22-1.98
11 16.4 (q) 16.0 0.93 (d, 6.9) 24.7 25.0 1.55
11’ 18.6 (q) 19.2 1.08 (d, 6.9)
12 23.3 23.1 1.03
12’ 21.2 21.5 0.96
1’ 136.4 135.6 7.22-7.38
2’/6’ 129.7 129.0 7.22-7.38
3’/5’ 128.0 128.8 7.22-7.38
4’ 127.0 127.3 7.22-7.38
aNMR data were compared with those acquired by Li et al. [16] in CDCl
3
.
Diketopiperazine Derivatives from Streptomyces SUK 25 1253
July 2017Vol. 27No. 7
activity against Mucor miehei [19]. However, in this current
study, compound 5 displayed activity against Enterococcus
raffinosus.
Biological Activity
Fraction FII exhibited activity against MRSA and
Enterococcus raffinosus. The isolated pure compounds from
FII were tested against ESKAPE pathogens. Compound 1
showed bioactivity only against MRSA 43300 with a zone
of inhibition at 15 mm. Compounds 3, 4, and 5 were active
only against Enterococcus raffinosus with a zone of inhibition
at 13, 14, and 13 mm, respectively. The pure compounds
were examined against the different test microorganisms,
as shown in Table 6. 
Cytotoxic Effects of C1 and C2 on HepaRG
Tested compounds 1 and 2 showed no toxicity towards
HepaRG cells, with IC
50
 values of 110.1± 1.2 and 103.2 ±
1.24 µg/ml for 1 and 2, respectively, as shown in Table 7
and Fig. 2.
Table 4. 1H NMR and 13C NMR data of compound 4 in MeODb.
Position
δ 1H (ppm),
multiplicity (J in Hz)
δ 13C 
(ppm)
δ 13C 
(ppm)a
1-NH 8.0 brs
2 168.4 (s) 167.41
3 3.66 (dd, 4.4. 1.6) 59.2 (d) 60.1
4-NH 8.0 brs
5 169.1 (s) 67.3
6 3.34 (dt, 4.9, 1.4) 55.0 (d) 55.9
7A 3.26 (dd, 1.1, 3.8) 37.8 (t) 38.7
7B 3.01 (dd, 13.8. 4.7)
8 136.3 (s) 137.2
9/13 7.22 (d, 6.9) 130.3 (d) 131.2
10/12 7.28 (t, 6.8) 127.9 (d) 128.8
11 7.23 (t, 7.2) 126.4 (d) 127.3
14 1.6 m 31.0 (d) 31.9
15 0.79, (t, 6.9) 18.2 (q) 19.1
15’ 0.42, (t, 6.9) 16.2 (q) 17.1
aNMR data were compared with those acquired by Stark and Hofmann [17] in
DMSO-d
6
.
bMeOD, Deuterated methanol.
Table 5. 1H NMR and 13C NMR data of compound 5 in MeODa.
Position
δ 1H (ppm)
multiplicity (J in Hz)
δ 13C
(ppm)
1 3.66 39.6 
2 1.25−1.38 32.3
3 1.25−1.38 26.7
4 1.25−1.38 27.1
5 1.25−1.38 29.5 
6 39.9
7 3.22 71.6
8 1.18 19.4
9 1.18 14.5
1’ 170.1
2’ 1.97 23.3
aMeOD, Deuterated methanol.
Table 6. Antimicrobial activity of the subfraction FII against
ESKAPE pathogens by the disk diffusion method.
Name of bacteria 
(ATCC)
1 2 3 4 5 Gentamicin
ER (49464) n.a. n.a. 13 14 13 20
MRSA (43300) 15 n.a. n.a. n.a. n.a. 22
KP n.a. n.a. n.a. n.a. n.a. 18
AB n.a. n.a. n.a. n.a. n.a. 17
PA (87853) n.a. n.a. n.a. n.a. n.a. 17
EA (51697) n.a. n.a. n.a. n.a. n.a. 20
The determined inhibition zone was in milliliter unit.
ER, Enterococcus raffinosus; SA, Staphylococcus aureus; KP, Klebsiella pneumoniae;
AB, Acinetobacter, baumanii; PA, Pseudomonas aeruginosa; and EA, Enterobacter
aerogenes; and n.a., no activity. 
Table 7. Data analysis from GraphPad Prism 5 to determine the
IC
50
 of compounds 1 and 2 against the HepaRG cell line. 
Log (inhibitor) vs. 
normalized response - 
Variable slope
1 2
Log IC
50
2.042 2.014
Hill slope 1.242 1.137
IC
50
110.1 103.2
Log IC
50
0.02299 0.01765
Hill slope 0.1191 0.08189
Confidence intervals 95% 95%
Log IC
50
1.983 to 2.101 1.968 to 2.059
Hill slope 0.9354 to 1.548 0.9261 to 1.347
IC
50
96.09 to 126.2 92.96 to 114.6
Degrees of freedom 5 5
R² 0.9843 0.9913
Absolute sum of squares 34.8 19.82
Sy.x 2.638 1.991
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Discussion
The antimicrobial bioactivity and cytotoxicity of the
isolated compounds were evaluated using several types of
bacteria and HepaRG cells, respectively. The ethyl acetate
extract of Streptomyces SUK 25 produced four active DKP
compounds and a N-(7-hydroxy-6-methyl-octyl)-acetamide.
The DKPs were identified as cyclo-(L-Val-L-Pro (1), cyclo-(L-
Phe-L-Pro) (2), cyclo-(L-Leu-L-Pro) (3), and cyclo-(L-Val-L-Phe)
(4). All pure compounds were isolated from fraction FII after
a series of chromatographic separation and purification by
HPLC. Structure elucidation was accomplished by HR-LC
ESI MS and NMR. The findings from this study are simillar
to an earlier work [20] on the isolation of four cyclic DKP
antibiotics, identified as streptocidins A-D, from the
mycelial extract of Streptomyces sp. Tü 6071. Moreover,
cyclo-(valyl-prolyl) has been isolated from the marine
actinomycete B 1758 [21], as well as cyclo-(L-Leu-L-Pro) from
Streptomyces sp. KH-614, which is taxonomically related to
Streptomyces lydicus. Cyclo-(L-Leu-L-Pro) demonstrated
antibacterial activity against VRE strains such as E. faecalis
(K-99-34), E. faecalis (K-00-184), and E. faecalis (K-00-221)
with MIC values of 12.5 µg/ml. Moreover, cyclo-(L-Leu-L-
Pro) was also described to be effective against three
leukemic cell lines at concentrations below 100 µg/ml [22].
Cyclo-(L-Gly-L-Pro) and cyclo-(L-Phe-4-OH-L-Pro) were isolated
from cultures of the marine bacterium Pseudoalteromonas
luteoviolacea [23]. A combination of cyclo-(L-Leu-L-Pro) and
cyclo-(L-Phe-L-Pro) exhibited increased bioactivity against
Escherichia coli, Staphylococcus aureus, Micrococcus luteus,
Candida albicans, and Cryptococcus neoformans with MIC values
of 0.25-0.5 µg/ml [24]. Furthermore, seven DKPs known as
cyclo-(L-Leu-L-Pro), cyclo-(L-Phe-L-Pro), cyclo-(Gly-L-Pro),
cyclo-(L-Pro-L-Pro), cyclo-(L-Pro-L-Val), cyclo-(L-Leu-L-trans-
4-OH-Pro), and cyclo-(L-Phe-L-trans-4-OH-Pro) were isolated
from a fermentation broth of Aspergillus fumigatus. These
fungal DKPs exhibited weak antibacterial activity, inhibiting
the growth of Staphylococcus aureus and Micrococcus luteus
at the concentration of 2.9 mmol/l [25]. In addition, cyclo-
(L-Leu-L-Pro), also known as gancidin W, from two
Streptomyces species inhibited the growth of VRE-resistant
Enterococcus faecalis strains with MIC values of 12.5 µg/ml
Fig. 2. Cytotoxic effects of compounds 1 and 2 on a cancer cell line (HepaRG).
Data are represent by the mean±SD of three independent experiments with each experiment conducted in triplicate. (A) and (C) present IC
50
values of compounds 1 and 2; 110.1 ± 1.2 and 103.2 ± 1.2 respectively. (B) and (D) IC
50
 values of compounds 1 and 2 using GraphPad Prism in Log
concentration Log (inhibitor) vs. normalized response - Variable slope. 
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[26]. The marine sponge Axinella sp. also yielded six DKPs
identified as cyclo-(threonyl-prolyl), cyclo-(seryl-prolyl), cyclo-
(alanyl-prolyl), cyclo-(leucyl-prolyl), cyclo-(valyl-prolyl), and
cyclo-(glycyl-prolyl) [27]. Along with the cyclic tetrapeptide
staphylopeptide A, five DKPs, cyclo-(L-Val-L-Pro), cyclo-(L-
Tyr-L-Pro), cyclo-(L-Ala-L-Pro), and (L-Phe-L-Trp) were
isolated from the culture broth of the marine bacterium
Staphylococcus sp. no. P-100826-4-6 [28].
HepaRG cells were obtained from a liver tumor of a female
patient suffering from hepatocarcinoma and hepatitis C
infection [11]. The HepaRG cell line has been described as a
tool in the prediction of hepatotoxicity in preclinical drug
development [11, 29]. The ability of these cells to express
cytochrome P450 as well as nuclear receptors, the major
hepatic membrane transporters, phase II enzymes, and
antioxidant enzymes, particularly in their differentiated
state, makes them a valuable in vitro model to perform
drug metabolism and toxicity studies [9]. In the present
work, compounds 1 and 2 showed no toxicity towards
HepaRG cells, with IC
50
 values of 110.1 ± 1.2 µg/ml, and
103.2 ± 1.24 µg/ml, respectively, as shown in Table 7 and
Fig. 2. The isolated compounds were categorized as non-toxic
as recommended by the National Cancer Institute. IC
50
values of crude extracts over 30 µg/ml were defined as
negative cytotoxicity. The results from this study is
comparable to an earlier work where a cyclodipeptide
mixture obtained from Pseudomonas aeruginosa strain PAO1
gave IC
50
 values of 530 and 660 µg/ml, against HeLa and
Caco-2 cells, respectively [30].
The most important biological activities of DKPs, such as
tryprostatins A and B, were demonstrated to treat tsFT210
cells at a IC
50
 concentration of 6.25, 50, and 12.5 µg/ml,
respectively. The DKPs arrested tsFT210 cells in the G2/M
phase [31, 32]. DKPs have displayed the ability to act as a
plasminogen activator inhibitor-1 (PAI-1) [33, 34]. The
mechanism of action of DKPs may lead to cause alteration
of cardiovascular and blood-clotting functions [35]. The effects
of acetylapoaranotin, acetylaranotin, and deoxyapoaranotin
DKPs on cell proliferation were tested in vitro using five
cancer cell lines (HCT116, AGS, A549, MCF-7, and HepG2)
and showed potent inhibition of cell proliferation in four
cancer cell lines with the exception of HepG2 cells [36]. A
mixture of DKPs that consisted of cyclo-(L-Pro-L-Tyr), cyclo-
(L-Pro-L-Val), and cyclo-(L-Pro-L-Phe) isolated from the
P. aeruginosa PAO1 strain was applied to human cells grown
in serum containing CM medium. The results obtained
showed that these DKPs caused a decrease in the viability
of HeLa and Caco-2 cell cultures, exhibiting 75% dead cells
following treatment with the DKP mix at 100 mg/ml. The
IC
50
 for that mix was 0.53 and 0.66 mg/ml for HeLa and
Caco-2 cells, respectively. In addition, DKPs have the
capability to inhibit the activity of regulatory LuxR-type
proteins that are involved in N-acylhomoserine lactone
dependent quorum sensing signaling [30]. 
In conclusion, this study demonstrates that endophytic
Streptomyces SUK 25 has the ability to produce various DKP
derivatives with potential bioactivity against some pathogenic
bacteria such as MRSA and Enterococcus raffinosus, with
low toxicity against HepaRG cells. This finding presents a
good potential natural source of new drugs for the treatment
of some infectious diseases. 
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